Last reviewed · How we verify
NCT04424212
ICBT for Mental Health Problems Related to the Coronavirus Pandemic
NA trial testing Intervention group CoronaCope in Depression and Quality of Life Related to the Coronavirus Pandemic in 76 participants. Completed in 1 October 2021.
10 September 2021
Quick facts
| Lead sponsor | Linkoeping University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 76 |
| Start date | 10 June 2020 |
| Primary completion | 10 September 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Intervention group CoronaCope
Conditions studied
- Depression and Quality of Life Related to the Coronavirus Pandemic — all drugs for Depression and Quality of Life Related to the Coronavirus Pandemic →
Sponsor
Linkoeping University
Who can join
18 and older, any sex, with Depression and Quality of Life Related to the Coronavirus Pandemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study seeks to investigate the effects of a guided internet-based cognitive behavioral therapy (ICBT) programme a on adult mental health problems related to the current coronavirus pandemic. ICBT will be compared to a wait-list control group. Participants will be recruited in Sweden with a nationwide recruitment.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Tailored internet-based psychological treatment for psychological problems during the COVID-19 pandemic: A randomized controlled trial.
Aminoff V, Bobeck J, Hjort S, Sörliden E, et al · · 2023 · cited 7× · PMID 37671335 · DOI 10.1016/j.invent.2023.100662 -
Experiences of Individually Tailored Internet-Based Cognitive Behavioral Therapy During the COVID-19 Pandemic: Qualitative Interview Study.
Aminoff V, Baltius M, Lundström E, Berg M, et al · · 2025 · PMID 40499158 · DOI 10.2196/66908
Verify or expand the search:
- PubMed search for NCT04424212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Linkoeping University trials
Trials by the same sponsor.
- NCT07494422 — A Path to Prevention of Elder Abuse in Long-term Care. Prevalence Study Among Staff in Long-term Care. · not yet recruiting
- NCT07485439 — Self-inspired & Tailored Autism Movement With Phystic App · NA · enrolling by invitation
- NCT07391540 — ICBT for Psychological Symptoms Related to Economy · NA · recruiting
- NCT07181213 — Genetic Predisposition to High Blood Pressure · NA · enrolling by invitation
- NCT07312136 — MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04424212 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Linkoeping University
- Last refreshed: 19 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04424212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing